emetine has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, T; Harada, Y; Hayakawa, F; Iriyama, C; Kato, S; Kiyoi, H; Kojima, Y; Kuno, S; Morishita, T; Sakamoto, A; Shimada, K; Shimada, S; Sugimoto, K; Tomita, A | 1 |
Coltman, CA; Panettiere, F | 1 |
2 other study(ies) available for emetine and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.
Topics: Animals; Apoptosis; Cancer-Associated Fibroblasts; Cell Survival; Coculture Techniques; Emetine; Gene Rearrangement; Glycolysis; Humans; Immunoblotting; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Middle Aged; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colonic Neoplasms; Diarrhea; Electrocardiography; Emetine; Female; Humans; Injections, Intravenous; Laryngeal Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Myositis; Nausea; Tachycardia; Thyroid Neoplasms; Tracheal Neoplasms; Urinary Bladder Neoplasms | 1971 |